BOSTON--(BUSINESS WIRE)--Intellectual property law firm Wolf, Greenfield & Sacks, P.C. today announced that Jeffrey D. Hsi, Ph.D. will join the firm as a shareholder. Having worked as a scientist, inventor, entrepreneur and counselor, Dr. Hsi brings this wide range of perspectives to his practice, which is devoted to all aspects of technology commercialization.
Dr. Hsi has nearly two decades of experience in corporate counseling, formation and execution of intellectual property strategy and patent prosecution and opinion work in the areas of chemistry, pharmaceuticals, biotechnology, health and beauty, agriculture, animal health, nutraceuticals, polymers, diagnostics and medical devices. He also advises on the development of intellectual property, and is experienced in establishing infrastructure for it. He has counseled multinational chemical and pharmaceutical companies, emerging biopharmaceutical companies, venture capital and financial institutions and academic and governmental research institutions throughout the world.
Among Dr. Hsi’s numerous accolades, he has been repeatedly listed in the “Intellectual Asset Management (IAM) Patent 1000 - The World’s Leading Patent Practitioners." Prior to joining Wolf Greenfield, he served as a partner at the law firm Locke Lord. He also previously served as in-house counsel to a biopharmaceutical start-up company where he created and managed the company’s patent law department. Under his guidance, the company’s patent law team developed a worldwide corporate intellectual property strategy and internal intellectual property policies.
“As an accomplished counselor and intellectual property strategist, Jeffrey Hsi will bring additional depth and value to our pharmaceutical, biotechnology and chemical and materials technologies practices,” said Tim Oyer, Wolf Greenfield’s president and managing partner. “Jeffrey has broad knowledge of pharmaceuticals and his background as a scientist, an inventor, an entrepreneur and an award-winning counselor will deliver unmatched value to our clients.”
“I am pleased to be joining Wolf Greenfield’s outstanding team,” said Dr. Hsi. “As one of the leading intellectual property law firms in New England, Wolf Greenfield’s strong reputation and commitment to clients is evident, and I look forward to contributing to the team’s success. I especially look forward to joining Wolf Greenfield’s pharmaceutical practice, where I will continue in the tradition of my father, whose career in the industry spanned almost four decades.”
A frequent guest lecturer and presenter, Dr. Hsi has been invited to speak internationally on various intellectual property issues and has lectured at the Harvard Extension School and at MIT Sloan School of Management. He is a graduate of Rutgers University School of Law and Kalamazoo College, and received his Ph.D. from the University of Michigan and his M.S. from Indiana University. Dr. Hsi is a member of numerous professional associations, and was recently appointed to the board of directors of the Asian Americans Advancing Justice | AAJC (Asian American Justice Center) in Washington, DC. He is a co-inventor on two U.S. patents and co-author of several scientific publications.
About Wolf Greenfield
Wolf, Greenfield & Sacks, P.C. is the largest Boston-based law firm focused solely on intellectual property (IP) law. The firm’s lawyers are technical and legal specialists at the forefront of their fields supporting leading companies, inventors, and research facilities with a full range of intellectual property portfolio management including patent, copyright and trademark acquisition, prosecution and litigation; opinions and strategic counseling; trade dress protection; intellectual property audits and due diligence; and licensing and other issues related to commercialization of intellectual property. Now in its ninth decade, Wolf Greenfield continues to represent innovators in the fields of biotechnology, chemical & materials technologies, pharmaceuticals, clean technology, electrical & computer technologies, mechanical technologies, medical devices, and consumer products.